Xconomy | San Diego - Business + Technology in the Exponential Economy

deals, Life Sciences, Ardea Biosciences

Ardea Biosciences Secures Venture Loan

Bruce V. Bigelow 11/13/08

Ardea Biosciences (Nasdaq:RDEA) says it has entered into an $8 million growth capital loan agreement with Oxford Finance Corp. and Silicon Valley Bank. Ardea President and CEO Barry Quart says the loan, which includes warrants entitling the lenders to buy 56,000 shares to 2015, provides greater flexibility in “ongoing partnering discussions” and allows the drug development company to fund operations into the second half of 2009.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call 858-202-0492


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.